IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal


PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In October 2023, Northern TK Venture (NTK), a subsidiary of IHH Healthcare, had filed a claim against the Japanese pharmaceuticals manufacturer saying it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018.

The company had initially claimed 20 billion yen (RM581.9mil) that Daiichi was ordered to pay as damages to NTK in November 2023.

After a report by an expert, NTK now claims compensation of between 4.24 billion rupees and 109.3 billion rupees.

IHH Healthcare, Asia’s largest healthcare group, had halted its open offer to buy an additional 26% stake in Fortis after Daiichi filed a contempt plea against Fortis founders, according to media reports.

Both Daiichi and Fortis did not immediately respond to a Reuters request for comment. — Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Australia’s high wage growth reinforces RBA’s inflation challenge
Global Energy Alliance seeks US$100mil fund
Santos to cut workforce by 10% after slump in annual profit
Global pepper prices expected to rise in 2026
Warner Bros considers Paramount’s proposal
Thai industrial sentiment rises in January
Officials urge caution ahead of US agreement
IMF team due on 26th for review, budget talks
Lagarde has not reached decision on ECB term
EV sales boom in Ethiopia�

Others Also Read